T/SZSMDA 008-2023 Active Group standards

T/SZSMDA 008-2023 Subcutaneous Allergen Immunotherapy Technique Operational Guidelines

T/SZSMDA 008-2023 Subcutaneous Allergen Immunotherapy Technique Operational Guidelines

Publish Date: 2023-07-25 Implement Date: 2023-08-01 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us
Price: $ 20.00
Out of stock

Basic Information

Standard Code: T/SZSMDA 008-2023
Standard Type: Group standards
Standard Status: Active
is_force_gb: no
CCS Name: -
ICS Name: Integrated medical science and healthcare devices
Publish Date: 2023-07-25
Implement Date: 2023-08-01

Scope

Scope: This document specifies the basic requirements, operating methods, handling of adverse reactions, and injection doses for the subcutaneous immunotherapy of allergens. This document is applicable to the operation of subcutaneous immunotherapy of allergens; Main technical content: This document specifies the basic requirements, operating methods, handling of adverse reactions, and injection doses for the subcutaneous immunotherapy of allergens. This document is applicable to the operation of subcutaneous immunotherapy of allergens. It is one of the allergen-specific immunotherapies, and the administration method is subcutaneous injection. General requirements for subcutaneous immunotherapy of allergens: site, equipment and drugs, management requirements, staffing and training, standard operating procedures for subcutaneous immunotherapy of allergens, handling of adverse reactions, dose adjustment, cluster therapy and shock therapy, etc. technical requirements.

Development Information

Related Standards

Contact Us